• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Turkey·Healthcare·SELEC.IS
Share

Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Stocks

TRY 324Last Updated 27.08.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

TRY 3.71B

TRY 324
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a crucial intermediary within the pharmaceutical supply chain, overseeing the distribution of medicinal products from manufacturers to hospitals and pharmacies. In addition to this core function, the company manages its own dedicated pharmaceutical storage facility. Established in 1958, its principal operations are based in Istanbul, Turkey. The organization is ultimately controlled as a subsidiary of Selçuk Ecza Holding A.S.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Unfavourable
2/7

The average target price of SELEC.IS is 146 and suggests 51.4% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation t

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.08.2026 17:18

"Hot Potato": Why Burry is Bearish on Build-A-Bear Stock

28.08.2026 16:45

Wendy's stock plummeted after Nelson Peltz's fund decided not to buy the company

28.08.2026 16:15

Gold mining stocks outperformed chipmakers' stocks in August. Who's in the black?

28.08.2026 15:50

Morgan Stanley saw a "unique opportunity" in SpaceX shares after their plunge

28.08.2026 15:39

Morning in New York: The Jackson Hole Mountains Stand in the Way of the AI Rally

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026